Sanofi (NEO:SAN)

Market Cap	141.12B -15.1%
Revenue (ttm)	79.37B +7.0%
Net Income	6.42B -56.6%
EPS	5.29 -55.7%
Shares Out	n/a
PE Ratio	21.98
Forward PE	8.41
Dividend	0.85 (8.38%)
Ex-Dividend Date	May 6, 2026

Volume	245
Open	9.72
Previous Close	10.20
Day's Range	9.36 - 9.72
52-Week Range	9.20 - 11.60
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for onc...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 74,846
• Stock Exchange: Cboe Canada
• Ticker Symbol: SAN

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 30, 2026

Data Sources Report a data error